SCALE-UP Utah Awarded $5 Million To Improve COVID-19 Testing Among Underserved and Vulnerable Populations

Across the US, COVID-19 is hitting some communities harder than others, Utah is no exception. In our state, Latinos make up 14 percent of the population but represent 40 percent of cases. 类似的, there are disproportionately high case and death rates among Pacific Islanders, 非裔美国人, 印第安人, 以及生活在低收入社区的犹他州人.

With a goal of reducing health disparities in Utah, the National Institutes of Health (NIH) has awarded $5 million to 瑞秋·赫斯，M.D., Guilherme Del Fiol, m.s.D., Ph.D., 犹他健康大学的教授 大卫·维特博士.D.亨茨曼癌症研究所和犹他大学健康研究所的研究员. 该团队领导着SCALE-UP犹他, an initiative that aims to increase the acceptance, 达到, 吸收, long-term sustainability of COVID-19 screening and testing. The initiative will be carried out in partnership with 12 community health center systems across the state that run 39 primary care clinics serving more than 115,000 patients—most of whom live in rural and underserved communities.

"SCALE-UP Utah brings together partners from across Utah to ensure that there is adequate screening and testing for all population groups with a specific emphasis on those experiencing higher rates of COVID-19 infection,韦特说。. "No one should be left behind in being protected from COVID-19."

U of U Health is one of 32 institutions that received an NIH award through the Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP)计划. The program supports both projects designed to rapidly implement COVID-19 testing strategies in populations disproportionately affected by the pandemic and research that aims to better understand COVID-19 testing patterns among these populations.

"It is critical that all Americans have access to rapid, COVID-19准确诊断, especially underserved and vulnerable populations who are bearing the brunt of this disease,弗朗西斯说。. 柯林斯,M.D., Ph.D.美国国立卫生研究院院长. "The RADx-UP program will help us better understand and alleviate the barriers to testing for those most vulnerable and reduce the burden of this disease."

SCALE-UP犹他州利用预先存在的优势, evidence-based interventions developed by the team at the Center for Health Outcomes and Population Equity (HOPE), led by Wetter at 亨茨曼癌症研究所 and the Center for Clinical and Translational Science at U of U Health. 这些包括:

• Initiating text messaging dialogues about testing and testing logistics between health care providers and patients who are at high risk for infection or severe disease.
• Designing information technology tools that prompt health care providers to ask, 建议, connect patients to COVID-19 screening and testing.
• Engaging patient navigators to motivate patients and address logistics and barriers that could otherwise prevent them from being tested for COVID-19.

The program is designed to roll out quickly and adapt as needed in order to reduce COVID-19-related health inequities. Wetter says an important goal of SCALE-UP Utah is to serve as a model for other health care systems that serve vulnerable and underserved populations.

Long-standing partnerships between the Center for Clinical and Translational Science, 亨茨曼癌症研究所, 犹他州社区卫生协会, 全州社区健康中心, the Utah Department of Health provide additional infrastructure and resources that will improve the 达到 of COVID-19 screening and testing.

在未来, the program can be readily adjusted and redeployed to meet additional health needs that arise during the pandemic. "SCALE-UP Utah will build an infrastructure that can be used for equitable dissemination of a COVID-19 vaccine once it becomes available,韦特说。.

# # #